Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map - Scorecard - MDSpire
Advertisement
Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map
Clinical Scorecard: Neuroimaging and Neurophysiological Markers for the Diagnosis and Prognosis of Mood Disorders, Anxiety Disorders, Obsessive-Compulsive Disorder, PTSD, and Substance Use Disorders: A Comprehensive Evidence Review
At a Glance
Category
Detail
Condition
Mood Disorders, Anxiety Disorders, OCD, PTSD, Substance Use Disorders
Key Mechanisms
Neuroimaging and neurophysiological biomarkers for diagnosis and treatment response.
Target Population
Adults with psychiatric disorders.
Care Setting
Clinical settings utilizing neuroimaging and neurophysiological assessments.
Key Highlights
Advancements in precision medicine for mental health through biomarkers.
Systematic collection of neuroimaging datasets shows promise for identifying psychiatric disorder biomarkers.
Challenges remain in translating neuroimaging techniques into clinical practice.
Evidence map conducted to assess the state of research on neuroimaging and neurophysiological tests.
Focus on diagnosis and prognosis of multiple mental health disorders.
Guideline-Based Recommendations
Diagnosis
Utilize neuroimaging techniques to improve diagnostic accuracy.
Management
Incorporate neurophysiological assessments in treatment planning.
Monitoring & Follow-up
Regularly evaluate treatment response using neuroimaging biomarkers.
Risks
Consider clinical heterogeneity and symptom overlap when interpreting neuroimaging results.
Patient & Prescribing Data
Adults with depressive disorders, bipolar disorder, anxiety disorders, OCD, PTSD, and SUD.
Precision medicine approaches may enhance treatment efficacy through tailored interventions.
Clinical Best Practices
Integrate neuroimaging and neurophysiological assessments into routine clinical evaluations.
Encourage participation in large-scale studies to advance understanding of psychiatric disorders.
by Catherine Sowerby, Adrienne Landsteiner, Kristen Ullman, Maylen Anthony, Caleb Kalinowski, Michele R. Spoont, Scott Sponheim, Kelvin Lim, Jose V. Pardo, Timothy J. Wilt, Wei Duan-Porter
